Pagan Douglas W. 4
4 · Paratek Pharmaceuticals, Inc. · Filed Apr 8, 2019
Insider Transaction Report
Form 4
Pagan Douglas W.
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2019-04-05−19,500→ 151,557 total - Disposition to Issuer
Common Stock
2019-04-05−16,250→ 70,807 total - Disposition to Issuer
Common Stock
2019-04-05−37,000→ 114,557 total - Disposition to Issuer
Common Stock
2019-04-05−27,500→ 87,057 total - Award
Common Stock
2019-04-05+30,000→ 100,807 total
Footnotes (5)
- [F1]Represents forfeiture of restricted stock units ("RSUs") in connection with the Reporting Person's resignation as Chief Financial Officer ("CFO") of the Issuer, which were granted on February 14, 2018 and previously reported in Table I.
- [F2]Represents forfeiture of RSUs in connection with the Reporting Person's resignation as CFO of the Issuer, which were granted on February 26, 2019 and previously reported in Table I.
- [F3]Represents forfeiture of performance-based RSUs ("PRSUs") in connection with the Reporting Person's resignation as CFO of the Issuer, which were granted on August 3, 2017 and previously reported in Table I.
- [F4]Represents forfeiture of PRSUs in connection with the Reporting Person's resignation as CFO of the Issuer, which were granted on February 14, 2018 and previously reporting in Table I.
- [F5]Represents RSUs granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Consulting Agreement, dated March 15, 2019, between the Issuer and the Reporting Person. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on December 23, 2019, subject to the Reporting Person's material compliance with the Consulting Agreement and the execution of a customary release.